Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Unlock the mysteries of pain management by harnessing the power of fear, stress, and emotion. Discover how the brain's ...
In a groundbreaking pilot study, researchers have found evidence that spinal cord stimulation could potentially benefit ...
SCI most often occurs when the spinal cord is subjected to a severe crush or contusion injury and typically results in severe functional impairment, including limb paralysis, aberrant pain ...
CARLSBAD, Calif.--(BUSINESS WIRE)-- Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious ...
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results